The 13 most recent market catalysts affecting $AVAH, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 28, 2026
Corporate Catalyst
Bullish
Impact 65
Barclays Maintains Overweight on Aveanna Healthcare Hldgs, Raises Price Target to $15
Barclays analyst Andrew Mok has maintained an 'Overweight' rating on Aveanna Healthcare Holdings (AVAH) and raised the price target from $9.50 to $15. This substantial increase in …
Aug 24, 2026
Corporate Catalyst
Bullish
Impact 75
Aveanna Healthcare shares are trading higher after RBC Capital maintained its Outperform rating on the stock and raised its price target from $10 to $16.
This headline indicates a strong positive catalyst for Aveanna Healthcare (AVAH). The maintained 'Outperform' rating combined with a 60% increase in the price target from a reputab…
Aug 24, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $16
RBC Capital analyst Ben Hendrix maintained an 'Outperform' rating on Aveanna Healthcare Holdings (AVAH) and raised the price target from $10 to $16. This substantial increase in th…
Aug 21, 2026
Corporate Catalyst
Bearish
Impact 85
Aveanna Healthcare Holdings shares are trading lower after the company announced the pricing of its secondary offering of 15 million shares at $11.75 per share.
The secondary offering of 15 million shares at a set price of $11.75 per share for Aveanna Healthcare Holdings (AVAH) is a significant corporate catalyst. This action increases the…
Aug 21, 2026
Corporate Catalyst
Neutral
Impact 75
Reported Earlier, Aveanna Healthcare Prices Secondary Offering Of 15M Common Shares At $11.75 Per Share
This secondary offering by Aveanna Healthcare (AVAH) is a significant corporate catalyst. The pricing of 15 million common shares at $11.75 per share, especially if below the previ…
Aug 20, 2026
Corporate Catalyst
Bearish
Impact 85
Aveanna Healthcare Holdings shares are trading lower after the company announced a secondary offering of 15 million shares.
A secondary offering of 15 million shares for Aveanna Healthcare Holdings (AVAH) is a significant corporate catalyst. This action increases the total number of outstanding shares, …
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 55
Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Raises Price Target to $15
Raymond James analyst John Ransom has maintained a 'Strong Buy' rating on Aveanna Healthcare Holdings (AVAH) and raised the price target from $13 to $15. This analyst action signal…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 75
Aveanna Healthcare shares are trading higher after BMO Capital maintained its Outperform rating on the stock and raised its price target from $10 to $14.
This headline indicates a strong positive catalyst for Aveanna Healthcare. The maintenance of an 'Outperform' rating combined with a 40% increase in the price target from a reputab…
Aug 14, 2026
Corporate Catalyst
Bullish
Impact 65
BMO Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $14
BMO Capital analyst Sean Dodge has maintained an 'Outperform' rating on Aveanna Healthcare Holdings (AVAH) and significantly raised the price target from $10 to $14. This action si…
Aug 13, 2026
Corporate Catalyst
Neutral
Impact 75
Aveanna Healthcare Hldgs FY2026 Revenue expected to be more than $2.680 vs $2.628B Est
Aveanna Healthcare Holdings filed an 8-K disclosing that its fiscal year 2026 revenue is now expected to be more than $2.680 billion, surpassing the analyst consensus estimate of $…
Aug 13, 2026
Corporate Catalyst
Neutral
Impact 75
CORRECTION: Aveanna Healthcare FY2026 Revenue expected to be more than $2.680B vs $2.625B Est
Aveanna Healthcare Holdings (AVAH) filed an 8-K to correct its FY2026 revenue guidance, raising the expectation to over $2.680 billion from the prior estimate of $2.625 billion. Th…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 75
Aveanna Healthcare Holdings shares are trading higher after the company reported better-than-expected Q2 financial results.
This headline signifies a positive corporate catalyst for Aveanna Healthcare Holdings. Better-than-expected financial results often lead to increased investor confidence, driving u…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 92
Aveanna Healthcare Q2 Adj. EPS $0.22 Beats $0.17 Estimate, Sales $670.483M Beat $638.619M Estimate
Aveanna Healthcare (AVAH) announced Q2 adjusted EPS of $0.22, surpassing the $0.17 consensus estimate by 29.41%, and sales of $670.483 million, beating the $638.619 million estimat…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.